Immediate Impact
2 from Science/Nature 51 standout
Citing Papers
Efficacy and Safety of Glucagon-Like Peptide-1 Receptor Agonists for Weight Loss Among Adults Without Diabetes
2025 Standout
Oral semaglutide 50 mg taken once per day in adults with overweight or obesity (OASIS 1): a randomised, double-blind, placebo-controlled, phase 3 trial
2023 Standout
Works of Daniel van Kammen being referenced
Topiramate Normalizes Hippocampal NPY-LI in Flinders Sensitive Line ‘Depressed’ Rats and Upregulates NPY, Galanin, and CRH-LI in the Hypothalamus: Implications for Mood-Stabilizing and Weight Loss-Inducing Effects
2003
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Daniel van Kammen | 134 | 36 | 74 | 52 | 9 | 263 | |
| R J Wyatt | 89 | 53 | 114 | 40 | 11 | 305 | |
| Cynthia D. Delmo | 118 | 69 | 66 | 58 | 11 | 331 | |
| RobertM. Post | 87 | 21 | 88 | 42 | 7 | 259 | |
| Patrizia Ferrero | 136 | 17 | 94 | 87 | 16 | 331 | |
| Viviana Tubazio | 101 | 24 | 96 | 83 | 6 | 302 | |
| Kerri A. Pierz | 112 | 51 | 81 | 49 | 9 | 309 | |
| D. Reina | 118 | 38 | 75 | 19 | 6 | 300 | |
| B.L. Jorissen | 104 | 26 | 51 | 54 | 7 | 325 | |
| Janowsky Ds | 132 | 30 | 78 | 92 | 17 | 320 | |
| Alexandra Kleimann | 56 | 52 | 45 | 51 | 11 | 247 |
All Works
Loading papers...